Norman Broadbent Plc (NBB) - Net Assets
Based on the latest financial reports, Norman Broadbent Plc (NBB) has net assets worth GBX2.13 Million GBX (≈ $258.67 USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX6.11 Million ≈ $742.92 USD) and total liabilities (GBX3.98 Million ≈ $484.25 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is Norman Broadbent Plc's equity to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX2.13 Million |
| % of Total Assets | 34.82% |
| Annual Growth Rate | 3.06% |
| 5-Year Change | 154.31% |
| 10-Year Change | -12.65% |
| Growth Volatility | 769.41 |
Norman Broadbent Plc - Net Assets Trend (1986–2025)
This chart illustrates how Norman Broadbent Plc's net assets have evolved over time, based on quarterly financial data. See NBB defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Norman Broadbent Plc (1986–2025)
The table below shows the annual net assets of Norman Broadbent Plc from 1986 to 2025. For live valuation and market cap data, see Norman Broadbent Plc market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | GBX2.13 Million ≈ $258.67 |
+66.35% |
| 2024-12-31 | GBX1.28 Million ≈ $155.50 |
-7.05% |
| 2023-12-31 | GBX1.38 Million ≈ $167.30 |
+105.22% |
| 2022-12-31 | GBX670.00K ≈ $81.52 |
-19.86% |
| 2021-12-31 | GBX836.00K ≈ $101.72 |
-24.41% |
| 2020-12-31 | GBX1.11 Million ≈ $134.57 |
-18.97% |
| 2019-12-31 | GBX1.36 Million ≈ $166.08 |
+7.65% |
| 2018-12-31 | GBX1.27 Million ≈ $154.28 |
-36.28% |
| 2017-12-31 | GBX1.99 Million ≈ $242.13 |
-18.24% |
| 2016-12-31 | GBX2.43 Million ≈ $296.15 |
+101.99% |
| 2015-12-31 | GBX1.21 Million ≈ $146.61 |
-28.70% |
| 2014-12-31 | GBX1.69 Million ≈ $205.62 |
-39.64% |
| 2013-12-31 | GBX2.80 Million ≈ $340.68 |
-13.07% |
| 2012-12-31 | GBX3.22 Million ≈ $391.90 |
+40.41% |
| 2011-12-31 | GBX2.29 Million ≈ $279.11 |
+134.56% |
| 2010-12-31 | GBX978.00K ≈ $118.99 |
+140.84% |
| 2009-12-31 | GBX-2.40 Million ≈ $-291.40 |
-329.41% |
| 2008-12-31 | GBX1.04 Million ≈ $127.02 |
+180.25% |
| 2007-12-31 | GBX-1.30 Million ≈ $-158.29 |
+23.61% |
| 2006-12-31 | GBX-1.70 Million ≈ $-207.21 |
+32.34% |
| 2005-12-31 | GBX-2.52 Million ≈ $-306.25 |
-88.54% |
| 2004-12-31 | GBX-1.33 Million ≈ $-162.43 |
+10.22% |
| 2003-12-31 | GBX-1.49 Million ≈ $-180.92 |
+0.13% |
| 2002-12-31 | GBX-1.49 Million ≈ $-181.17 |
-137.86% |
| 2001-12-31 | GBX-626.00K ≈ $-76.17 |
-113.20% |
| 2000-12-31 | GBX4.74 Million ≈ $577.09 |
+445.20% |
| 2000-07-31 | GBX-1.37 Million ≈ $-167.18 |
-166.41% |
| 1999-07-31 | GBX2.07 Million ≈ $251.74 |
-21.21% |
| 1998-07-31 | GBX2.63 Million ≈ $319.51 |
+28.54% |
| 1997-07-31 | GBX2.04 Million ≈ $248.57 |
+19.75% |
| 1996-07-31 | GBX1.71 Million ≈ $207.57 |
+4165.00% |
| 1995-07-31 | GBX40.00K ≈ $4.87 |
+103.33% |
| 1994-07-31 | GBX-1.20 Million ≈ $-146.13 |
-218.79% |
| 1993-01-31 | GBX1.01 Million ≈ $123.01 |
+301.39% |
| 1992-01-31 | GBX-502.00K ≈ $-61.08 |
-120.97% |
| 1991-01-31 | GBX2.39 Million ≈ $291.28 |
-37.25% |
| 1990-01-31 | GBX3.81 Million ≈ $464.18 |
+3.30% |
| 1989-01-31 | GBX3.69 Million ≈ $449.33 |
+34.73% |
| 1988-01-31 | GBX2.74 Million ≈ $333.50 |
+163.30% |
| 1987-01-31 | GBX1.04 Million ≈ $126.66 |
+62.91% |
| 1986-01-31 | GBX639.00K ≈ $77.75 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Norman Broadbent Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1804200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX6.40 Million | 300.85% |
| Other Components | GBX14.21 Million | 668.25% |
| Total Equity | GBX2.13 Million | 100.00% |
Norman Broadbent Plc Competitors by Market Cap
The table below lists competitors of Norman Broadbent Plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Presto Automation Inc.
NASDAQ:PRST
|
$41.85K |
|
PTT Exploration and Production Public Company Limited
F:PTTG
|
$41.89K |
|
Phoenix Global Mining Ltd
LSE:PXC
|
$42.05K |
|
Indus Gas Limited
LSE:INDI
|
$42.30K |
|
London & Associated Properties
LSE:LAS
|
$41.53K |
|
KCR Residential Reit PLC
LSE:KCR
|
$41.07K |
|
Futura Medical
LSE:FUM
|
$41.02K |
|
Feedback PLC
LSE:FDBK
|
$40.78K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Norman Broadbent Plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,278,000 to 2,126,000, a change of 848,000 (66.4%).
- Net income of 620,000 contributed positively to equity growth.
- Other factors increased equity by 228,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX620.00K | +29.16% |
| Other Changes | GBX228.00K | +10.72% |
| Total Change | GBX- | 66.35% |
Book Value vs Market Value Analysis
This analysis compares Norman Broadbent Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 197.27x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.04x to 197.27x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1986-01-31 | GBX5071.43 | GBX185.00 | x |
| 1987-01-31 | GBX4603.17 | GBX185.00 | x |
| 1988-01-31 | GBX5940.37 | GBX185.00 | x |
| 1989-01-31 | GBX7237.15 | GBX185.00 | x |
| 1990-01-31 | GBX6296.17 | GBX185.00 | x |
| 1991-01-31 | GBX3931.78 | GBX185.00 | x |
| 1992-01-31 | GBX-1043.66 | GBX185.00 | x |
| 1993-01-31 | GBX35.56 | GBX185.00 | x |
| 1995-07-31 | GBX-8.82 | GBX185.00 | x |
| 1996-07-31 | GBX7.34 | GBX185.00 | x |
| 1997-07-31 | GBX10.17 | GBX185.00 | x |
| 1998-07-31 | GBX15.38 | GBX185.00 | x |
| 1999-07-31 | GBX9.69 | GBX185.00 | x |
| 2001-12-31 | GBX-1.02 | GBX185.00 | x |
| 2002-12-31 | GBX-2.46 | GBX185.00 | x |
| 2003-12-31 | GBX-2.46 | GBX185.00 | x |
| 2004-12-31 | GBX-1.91 | GBX185.00 | x |
| 2005-12-31 | GBX-3.61 | GBX185.00 | x |
| 2006-12-31 | GBX-1.67 | GBX185.00 | x |
| 2007-12-31 | GBX-0.98 | GBX185.00 | x |
| 2008-12-31 | GBX0.77 | GBX185.00 | x |
| 2009-12-31 | GBX-0.70 | GBX185.00 | x |
| 2010-12-31 | GBX0.18 | GBX185.00 | x |
| 2011-12-31 | GBX0.24 | GBX185.00 | x |
| 2012-12-31 | GBX0.28 | GBX185.00 | x |
| 2013-12-31 | GBX0.21 | GBX185.00 | x |
| 2014-12-31 | GBX0.13 | GBX185.00 | x |
| 2015-12-31 | GBX0.09 | GBX185.00 | x |
| 2016-12-31 | GBX0.10 | GBX185.00 | x |
| 2017-12-31 | GBX0.05 | GBX185.00 | x |
| 2018-12-31 | GBX0.02 | GBX185.00 | x |
| 2019-12-31 | GBX0.02 | GBX185.00 | x |
| 2020-12-31 | GBX0.02 | GBX185.00 | x |
| 2021-12-31 | GBX0.01 | GBX185.00 | x |
| 2022-12-31 | GBX0.01 | GBX185.00 | x |
| 2023-12-31 | GBX0.02 | GBX185.00 | x |
| 2024-12-31 | GBX0.02 | GBX185.00 | x |
| 2025-12-31 | GBX0.94 | GBX185.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Norman Broadbent Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 29.16%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.09%
- • Asset Turnover: 2.48x
- • Equity Multiplier: 2.87x
- Recent ROE (29.16%) is above the historical average (-17.08%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1986 | -30.05% | -4.15% | 2.06x | 3.52x | GBX-255.90K |
| 1987 | -17.59% | -2.23% | 2.11x | 3.74x | GBX-240.00K |
| 1988 | 13.67% | 4.12% | 1.30x | 2.55x | GBX95.00K |
| 1989 | 18.76% | 5.12% | 1.24x | 2.94x | GBX320.80K |
| 1990 | -14.43% | -4.37% | 1.13x | 2.92x | GBX-924.40K |
| 1991 | -60.14% | -12.11% | 1.05x | 4.74x | GBX-1.66 Million |
| 1992 | 0.00% | -21.09% | 1.82x | 0.00x | GBX-2.81 Million |
| 1993 | -242.91% | -5.95% | 2.27x | 17.94x | GBX-660.10K |
| 1995 | 0.00% | -31.55% | 7.81x | 0.00x | GBX-9.52 Million |
| 1996 | 35.05% | 3.26% | 1.46x | 7.36x | GBX208.70K |
| 1997 | 34.79% | 3.44% | 1.76x | 5.76x | GBX290.00K |
| 1998 | -6.20% | -0.80% | 1.60x | 4.82x | GBX-298.00K |
| 1999 | -43.28% | -3.29% | 2.05x | 6.41x | GBX-694.30K |
| 2001 | 0.00% | -294.62% | 0.75x | 0.00x | GBX-5.47 Million |
| 2002 | 0.00% | -64.26% | 0.95x | 0.00x | GBX-714.10K |
| 2003 | 0.00% | 0.16% | 1.01x | 0.00x | GBX150.70K |
| 2004 | 0.00% | -13.67% | 1.04x | 0.00x | GBX-41.50K |
| 2005 | 0.00% | 2.91% | 1.25x | 0.00x | GBX297.70K |
| 2006 | 0.00% | 13.97% | 1.59x | 0.00x | GBX535.30K |
| 2007 | 0.00% | 12.88% | 1.70x | 0.00x | GBX532.10K |
| 2008 | 34.20% | 10.90% | 0.33x | 9.49x | GBX252.60K |
| 2009 | 0.00% | -57.28% | 2.05x | 0.00x | GBX-3.22 Million |
| 2010 | 109.51% | 17.53% | 1.46x | 4.27x | GBX973.20K |
| 2011 | -24.46% | -8.13% | 1.54x | 1.96x | GBX-790.40K |
| 2012 | -4.13% | -1.66% | 1.41x | 1.76x | GBX-434.60K |
| 2013 | -38.08% | -13.91% | 1.49x | 1.84x | GBX-1.33 Million |
| 2014 | -76.32% | -19.59% | 1.90x | 2.05x | GBX-1.68 Million |
| 2015 | -30.15% | -5.23% | 2.09x | 2.76x | GBX-601.90K |
| 2016 | -53.57% | -23.03% | 1.40x | 1.66x | GBX-1.55 Million |
| 2017 | -75.31% | -23.65% | 1.47x | 2.17x | GBX-1.75 Million |
| 2018 | -58.47% | -8.10% | 2.06x | 3.51x | GBX-893.50K |
| 2019 | -2.91% | -0.34% | 2.31x | 3.70x | GBX-173.00K |
| 2020 | -29.11% | -4.12% | 2.04x | 3.46x | GBX-432.60K |
| 2021 | -76.79% | -9.80% | 1.54x | 5.10x | GBX-725.60K |
| 2022 | -50.45% | -3.89% | 2.10x | 6.17x | GBX-405.00K |
| 2023 | 22.47% | 2.51% | 2.36x | 3.79x | GBX171.50K |
| 2024 | -12.36% | -1.45% | 2.46x | 3.47x | GBX-285.80K |
| 2025 | 29.16% | 4.09% | 2.48x | 2.87x | GBX407.40K |
Industry Comparison
This section compares Norman Broadbent Plc's net assets metrics with peer companies in the Staffing & Employment Services industry.
Industry Context
- Industry: Staffing & Employment Services
- Average net assets among peers: $87,032,788
- Average return on equity (ROE) among peers: 15.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Norman Broadbent Plc (NBB) | GBX2.13 Million | -30.05% | 1.87x | $41.75K |
| Empresaria Group plc (EMR) | $46.70 Million | 10.28% | 1.73x | $134.28K |
| GATTACA Plc (GATC) | $35.11 Million | -1.24% | 2.11x | $516.01K |
| Hays plc (HAS) | $216.40 Million | 33.13% | 3.09x | $7.17 Million |
| Hercules Site Services PLC (HERC) | $6.84 Million | 4.69% | 3.96x | $284.34K |
| Pagegroup PLC (PAGE) | $306.49 Million | 25.15% | 1.30x | $4.77 Million |
| RTC Group plc (RTC) | $3.66 Million | 11.52% | 1.00x | $160.39K |
| Robert Walters (RWA) | $983.00K | 26.25% | 2.18x | $680.29K |
| Staffline Group Plc (STAF) | $38.60 Million | 12.44% | 5.15x | $553.80K |
| SThree plc (STEM) | $128.52 Million | 13.19% | 1.63x | $2.55 Million |
About Norman Broadbent Plc
Norman Broadbent plc, together with its subsidiaries, provides professional services in the United Kingdom and internationally. It provides board and search, interim management and consulting, research and insight, leadership consulting, talent acquisition, and advisory services. The company serves consumers; financial services; industrials; TMT; life sciences & healthcare; civil society, educati… Read more